Development of a Novel Test for Simultaneous Bacterial Identification and Antibiotic Susceptibility

Area of Science:

• Microbiology
• Immunology
• Infectious Diseases

Background:

• Current methods for determining antimicrobial susceptibility require several days, leading to prolonged use of broad-spectrum antibiotics.
• This delay contributes to the growing problem of bacterial resistance.
• Rapid diagnostics are crucial for effective patient management and infection control.

Purpose of the Study:

• To develop a novel assay for simultaneous pathogen identification and antimicrobial susceptibility testing.
• To reduce the time required for susceptibility results compared to traditional methods.
• To improve patient outcomes and mitigate antibiotic resistance.

Main Methods:

• Microtiter wells were coated with a specific polyclonal antibody to capture target pathogens.
• Bacterial suspensions, with and without antibiotics, were incubated in the wells.
• Captured bacteria were detected after washing, with incubation times varying for identification and susceptibility determination.

Main Results:

• Pathogen detection (Group B Streptococcus, Enterococcus faecalis, Neisseria gonorrhoeae) achieved at 10^5 bacteria/mL within 20 minutes.
• Antimicrobial susceptibility was determined within 6 hours for GBS and Enterococcus.
• Increased sensitivity (down to 10^1 bacteria/mL) and results obtained within 18-24 hours post-culture.

Conclusions:

• The novel assay enables rapid and accurate pathogen identification.
• Simultaneous antimicrobial susceptibility testing is achievable in a significantly reduced timeframe.
• This assay holds potential for improving clinical decision-making and combating antibiotic resistance.